Dec. 1, 2004 -- The U.S. Food and Drug Administration (FDA) approved in September revisions to safety labeling to advise healthcare professionals of the following changes: use of nalidixic acid may be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback